Crossmark

Health technology assessment and price negotiation alignment for rare disorder drugs in Canada: Who benefits?

Published Online: 2022-06-13

Published Print: 2022-12

Authors

Rawson, Nigel S. B. https://orcid.org/0000-0001-6843-4890
License Information

Text and Data Mining valid from 2022-06-13

Version of Record valid from 2022-06-13
More Information

Article History

Received: 4 March 2022

Accepted: 6 June 2022

First Online: 13 June 2022

Declarations

:

: Not applicable.

: Not applicable.

: The author declares no competing interests.

Document is current